
    
      This study has 2 phases:

      The study ID 107064 corresponds to objectives & outcome measures evaluated from day 0 until
      day 51.

      The study ID 107217 corresponds to objectives & outcome measures evaluated at day 180.

      The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep
      2007.
    
  